Altogether, our knowledge deliver proof with the prospective of combining CX-5461 and PARPi for increasing the therapy of HR-deficient HGSOC. We display that CX-5461 improves the artificial lethal interaction of PARPi with HRD and Obviously clearly show that CX-5461 has a different system of action